David Krige Email & Phone Number
Chief Development Officer (CDO) @ Accession Therapeutics Limited
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
David Krige Location
- Oxford, GB
David Krige Work
- 2025 -now Chief Development Officer (CDO) @
- 2022 -2025 Head of Translational Sciences @
- 2019 -2022 Vice President, Translational Medicine @
- 2018 -2019 Director of Translational Medicine @
- 2014 -2018 Head of Biomarkers @
- 2012 -2014 Head of Drug Discovery, Science Funding Dept @
- 2004 -2012 Group and Project Leader, Biology @ Chroma Therapeutics
- 2000 -2003 Team Leader, Gene Discovery @
- 1994 -2000 Senior Scientist @ British Biotech
- 1990 -1994 PhD @ Royal Free Hospital, University of London
David Krige Education
- Royal Free Hospital, University of London
PhD (Biochemistry)
1990-1994 - UCL
MSc (Applied Molecular Biology and Biotechnology; distinction)
1988-1989 - Queen Mary University of London
BSc (Genetics)
1985-1988
David Krige Skills
- Molecular Biology
- Biochemistry
- Genomics
- Cell Based Assays
- Drug Discovery
- Oncology
- Cell Biology
- Customer Service
- Biomarkers
- Research
- Data Analysis
David Krige Summary
- David Krige, based in Oxford, GB, is currently a Chief Development Officer (CDO) at Accession Therapeutics Limited. David Krige brings experience from previous roles at Accession Therapeutics Limited, PsiOxus Therapeutics Ltd and Immunocore. David Krige holds a 1990 - 1994 PhD in Biochemistry @ Royal Free Hospital, University of London. With a robust skill set that includes Molecular Biology, Biochemistry, Genomics, Cell Based Assays, Drug Discovery and more. David Krige has 1 emails on RocketReach.
Looking for a different David Krige?
Find contact details for 700 million professionals.
Top Accession Therapeutics Limited Employees
Lucie Bouard
Senior Scientist
Oxford, GB
Ryea Maswood
Principal Scientist - CMC
Oxford, GB
Emily Trimby
Senior Scientist
Horspath, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co